Dr. Lal PathLabs Limited's market cap is currently ₹236.35B. The company's EPS TTM is ₹48.256; its P/E ratio is 58.59; and it has a dividend yield of 1.07%. Dr. Lal PathLabs Limited is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is ₹11.74. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	₹ 22.27B	₹ 20.17B	₹ 20.87B	₹ 15.81B	₹ 13.30B
Gross Profit	₹ 12.79B	₹ 15.70B	₹ 13.00B	₹ 11.84B	₹ 10.32B
Operating Income	₹ 8.65B	₹ 3.40B	₹ 4.55B	₹ 3.60B	₹ 2.71B
EBITDA	₹ 6.78B	₹ 5.32B	₹ 6.13B	₹ 4.88B	₹ 3.99B
Net Income	₹ 3.58B	₹ 2.39B	₹ 3.45B	₹ 2.92B	₹ 2.26B
Balance Sheet
Cash & Short-Term Investments	₹ 9.43B	₹ 8.51B	₹ 6.82B	₹ 9.84B	₹ 7.32B
Total Assets	₹ 24.56B	₹ 23.86B	₹ 23.53B	₹ 16.61B	₹ 13.74B
Total Debt	₹ 2.47B	₹ 4.20B	₹ 5.32B	₹ 1.50B	₹ 1.29B
Net Debt	₹ -1.14B	₹ 1.56B	₹ 1.54B	₹ -939.32M	₹ -673.49M
Total Liabilities	₹ 5.71B	₹ 6.86B	₹ 8.10B	₹ 3.85B	₹ 3.20B
Stockholders' Equity	₹ 18.49B	₹ 16.66B	₹ 15.08B	₹ 12.45B	₹ 10.33B
Cash Flow
Free Cash Flow	₹ 4.78B	₹ 4.11B	₹ -294.49M	₹ 3.39B	₹ 2.04B
Operating Cash Flow	₹ 5.35B	₹ 4.56B	₹ 4.47B	₹ 3.98B	₹ 2.84B
Investing Cash Flow	₹ -242.69M	₹ -2.87B	₹ -4.49B	₹ -2.12B	₹ -261.14M
Financing Cash Flow	₹ -4.14B	₹ -2.83B	₹ 1.36B	₹ -1.39B	₹ -1.90B

Currency in INR

Dr. Lal PathLabs Limited Earnings and Revenue History

Income Statement >

Dr. Lal PathLabs Limited Debt to Assets

Balance Sheet >

Dr. Lal PathLabs Limited Cash Flow

Cash Flow >

Dr. Lal PathLabs Limited Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing